North America radiotherapy market is projected to register a CAGR of 5.9% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation:
North America Radiotherapy Market, By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals and Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer and Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2027
Some of the major factors contributing to the growth of the North America radiotherapy market are:
• Increasing demand of radiotherapy treatment among the cancer patients.
• Increasing adoption of non-surgical treatment procedure.
Market Players:
The key market players for North America radiotherapy market are listed below:
• Varian Medical Systems, Inc.
• ProTom International
• Mevion Medical Systems
• VIEWRAY TECHNOLOGIES, INC. (A Subsidiary of ViewRay)
• Siemens Healthcare GmbH
• Elekta AB
• Accuray Incorporated
• IBA Worldwide
• Eckert & Ziegler BEBIG
• RaySearch Laboratories
• Brainlab AG
• Koninklijke Philips N.V.
• GE Healthcare
• Hitachi, Ltd.
• Advanced Accelerator Applications (A Subsidiary of Novartis AG)
• Provision Healthcare.
• Nordion (Canada) Inc.
• Sumitomo Heavy Industries, Ltd.
• CIVCO Radiotherapy (A Subsidiary of Roper Technologies)
• Isoray Inc